Author

A. Bronstein

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Sep 2026

Outcomes of long-term responders to immunotherapy in the treatment of advanced non-small cell lung cancer (NSCLC). A retrospective regional study.

BACKGROUND For advanced lung cancer patients, an increasing number of long responders to Immune Checkpoint Inhibitors (ICI) is observed. Thus, the optimal treatment duration remains unclear whereas indefinite treatment is associated to immune-related adverse events (irAEs) and financial burden. OBJECTIVE To describe...

Arnaud De Gunten, A. Mogenet, A. Bronstein et al. · Lung Cancer · 0 citations

Open access Aug 2026

Peripheral muscle dysfunction persists in the era of highly effective CFTR modulators in cystic fibrosis.

Altered muscle performance cannot be explained solely by muscle deconditioning and lower muscle size, suggesting intrinsic muscle alterations, and support the need for comprehensive assessment of peripheral muscle function and the continued prioritisation of interventions aiming to optimise muscle health.

A. Bronstein, Elise Zitta, O. Saidi et al. · Journal of Cystic Fibrosis · 0 citations